Literature DB >> 19944677

Vascular insulin resistance in prehypertensive rats: role of PI3-kinase/Akt/eNOS signaling.

Rong Li1, Haifeng Zhang, Wenqing Wang, Xiaoming Wang, Yuxiao Huang, Chen Huang, Feng Gao.   

Abstract

It is well known that systemic insulin resistance is closely associated with the metabolic syndrome including type 2 diabetes and hypertension. However, it remains unclear whether vascular insulin resistance acts as an early etiologic factor for the development of hypertension. Male spontaneously hypertensive rats (SHRs) aged 5 weeks (young) and 15 weeks (adult) were studied and vascular insulin resistance was assessed as the function of isolated aortic vasodilatory response to insulin in vitro. Compared with Wistar-Kyoto (WKY) rats, adult SHRs exhibited significant hypertension with significantly decreased aortic vasodilatation to insulin, whereas young SHRs had normal blood pressure but exhibited similar vascular insulin resistance. Both young and adult SHRs showed significant downregulated expression of PI3-kinase and decreased insulin-stimulated phosphorylations of Akt and eNOS in vascular tissues. Treatment with rosiglitazone (RSG), an insulin sensitizer, for 2 weeks increased vascular PPARgamma expression and restored PI3-kinase/Akt/eNOS-mediated signaling pathway only in young SHRs. More importantly, this treatment improved aortic vasodilatory response to insulin in young but not in adult SHRs. In summary, vascular insulin resistance, characterized by the impairment of PI3-kinase/Akt/eNOS-mediated signaling in vascular endothelium, may play important roles in endothelial dysfunction and subsequent development of hypertension in normotensive young SHRs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19944677     DOI: 10.1016/j.ejphar.2009.11.038

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  27 in total

1.  FM19G11 reverses endothelial dysfunction in rat and human arteries through stimulation of the PI3K/Akt/eNOS pathway, independently of mTOR/HIF-1α activation.

Authors:  M El Assar; J M Sánchez-Puelles; I Royo; E López-Hernández; A Sánchez-Ferrer; J L Aceña; L Rodríguez-Mañas; J Angulo
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

Review 2.  Submaximal PPARγ activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders.

Authors:  Pitchai Balakumar; Sonam Kathuria
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 3.  Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence.

Authors:  Hong Sheng Cheng; Wei Ren Tan; Zun Siong Low; Charlie Marvalim; Justin Yin Hao Lee; Nguan Soon Tan
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

4.  Loss of renal SNX5 results in impaired IDE activity and insulin resistance in mice.

Authors:  Fengmin Li; Jian Yang; Van Anthony M Villar; Laureano D Asico; Xiaobo Ma; Ines Armando; Hironobu Sanada; Minoru Yoneda; Robin A Felder; Pedro A Jose; Xiaoyan Wang
Journal:  Diabetologia       Date:  2017-10-28       Impact factor: 10.122

5.  Insulin resistance, obesity, hypertension, and renal sodium transport.

Authors:  Shoko Horita; George Seki; Hideomi Yamada; Masashi Suzuki; Kazuhiko Koike; Toshiro Fujita
Journal:  Int J Hypertens       Date:  2011-04-12       Impact factor: 2.420

Review 6.  The pathophysiology of hypertension in patients with obesity.

Authors:  Vincent G DeMarco; Annayya R Aroor; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2014-04-15       Impact factor: 43.330

7.  Strict glucose control and artificial regulation of the NO-ADMA-DDAH system in order to prevent endothelial dysfunction.

Authors:  Saskia J H Brinkmann; E A Wörner; Paul A M van Leeuwen
Journal:  J Physiol       Date:  2016-06-01       Impact factor: 5.182

8.  The novel ATP-sensitive potassium channel opener iptakalim prevents insulin resistance associated with hypertension via restoring endothelial function.

Authors:  Yu Wang; Fu-hu Zeng; Chao-liang Long; Zhi-yuan Pan; Wen-yu Cui; Ru-huan Wang; Guo-shu Liu; Hai Wang
Journal:  Acta Pharmacol Sin       Date:  2011-11-07       Impact factor: 6.150

9.  Increased cerebral oxygen metabolism and ischemic stress in subjects with metabolic syndrome-associated risk factors: preliminary observations.

Authors:  Ken Uchino; Ridwan Lin; Syed F Zaidi; Hiroto Kuwabara; Donald Sashin; Nicholas Bircher; Yue-Fang Chang; Maxim D Hammer; Vivek Reddy; Tudor G Jovin; Nirav Vora; Mouhammad Jumaa; Lori Massaro; Julia Billigen; Fernando Boada; Howard Yonas; Edwin M Nemoto
Journal:  Transl Stroke Res       Date:  2010-09-01       Impact factor: 6.829

Review 10.  Cellular mechanisms underlying obesity-induced arterial stiffness.

Authors:  Annayya R Aroor; Guanghong Jia; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-11-22       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.